MNTA 'ReadMeFirst' updated:
MNTA inks worldwide FoB partnership with BAX;
‘biobucks’ scorecard for the MNTA-BAX partnership;
BAX pays for post-IND development and commercialization of 1st two FoB’s;
timing of MNTA’s opt-in for FoB’s #3-#6;
first two FoB’s in BAX partnership could be Orencia and Humira;
link to MNTA’s Orencia paper in Nature Biotechnology;
Humira factoids;
an interchangeable Humira FoB has colossal upside;
musings on the terms of the BAX deal (rkrw);
musings on the terms of the BAX deal (Dew);
musings on BAX as the chosen partner;
2012-2014 news flow;
four bullish things that could happen at any time.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=70270433